Enflame IPO 4,073x oversubscribed in Shanghai amid Nvidia rivalry
Synopsis
Enflame Technology's Shanghai IPO was oversubscribed 4,073 times by roughly 7 million retail investors — making its 0.025% allocation rate tighter than any of its 'four little dragons' peers — as China's domestic AI chip race enters a critical new phase.
Key Takeaways
Enflame Technology 's Star Market IPO retail tranche was oversubscribed 4,073 times , with approximately 7 million investors bidding for 42.1 billion shares .
The individual allocation rate stood at just 0.025 per cent , one of the lowest on mainland China in 2026 , alongside Unitree Robotics at 0.018 per cent .
The IPO is priced at 142.18 yuan (US$21.16) per share, targeting gross proceeds of 6.12 billion yuan (US$910.9 million) .
Enflame is the last of China 's AI chip ' four little dragons ' — alongside Moore Threads , Biren Technology , and MetaX — to go public.
Peer listings set high expectations: Moore Threads surged 693 per cent and MetaX gained 425 per cent on their respective debut days in December .
IPO funds will support development of Enflame's fifth- and sixth-generation AI chips .
Enflame Technology, a Tencent Holdings-backed AI chipmaker based in Shanghai, has recorded one of China's most feverish stock market debuts of 2026, with the retail tranche of its 6.12 billion yuan (US$910.9 million) initial public offering on the Star Market oversubscribed by 4,073 times — a signal of surging investor conviction in domestically produced alternatives to Nvidia chips.
Record demand, razor-thin allocation
Approximately 7 million online investors submitted orders for 42.1 billion shares, according to the company's filing to the exchange on Wednesday, 3 September 2026. The avalanche of bids translated into an individual allocation rate of just 0.025 per cent — meaning the overwhelming majority of applicants will walk away empty-handed.
That figure places Enflame alongside robotics firm Unitree Robotics, which posted an allocation rate of 0.018 per cent — roughly one successful lot for every 5,500 applications — as one of the most tightly rationed listings on the mainland this year.
The competitive backdrop
Enflame is widely regarded as one of China's 'four little dragons' in the AI chip sector, a cohort that also includes Moore Threads, Biren Technology, and MetaX. It is the last of the four to go public, and retail investors appear to be pricing in a blockbuster debut.
Its allocation rate of 0.025 per cent is already tighter than those of its peers: MetaX registered 0.033 per cent and Moore Threads posted 0.036 per cent at their respective listings. Both rivals debuted in December, with first-day gains of 693 per cent and 425 per cent respectively — benchmarks the market is now using to calibrate expectations for Enflame.
Why it matters
The listing underscores Beijing's accelerating drive for semiconductor self-sufficiency, with domestic AI chipmakers attracting capital that might previously have flowed toward foreign-listed technology stocks. Enflame's IPO proceeds are earmarked for the research, development, and production of its fifth- and sixth-generation AI chips, deepening its technical roadmap at a time when US export controls continue to limit Chinese firms' access to leading-edge Nvidia hardware.
Each share was priced at 142.18 yuan (US$21.16), and the company's ability to command that valuation amid a crowded domestic chip landscape reflects both its Tencent Holdings backing and its established position in large-model inference workloads.
What's next
With all four of China's AI chip 'little dragons' now publicly listed, the sector enters a new phase of scrutiny — one defined less by IPO euphoria and more by revenue execution, chip performance benchmarks, and the pace of enterprise adoption. Investors and industry watchers will be closely monitoring Enflame's first-day trading performance against the 693 per cent and 425 per cent bars set by its peers, as well as its progress on next-generation chip development in the quarters ahead.
Point of View
Creating a captive investor base with few alternative outlets. What mainstream coverage underweights is the execution risk now facing all four 'little dragons' simultaneously: public markets will demand revenue proof, not just patriotic momentum, within the next two to three reporting cycles. The real test is whether Enflame's next-generation chips can close the performance gap with leading-edge Nvidia hardware fast enough to justify the valuations the market is already pricing in.
NationPress
3 Sept 2026
Frequently Asked Questions
How oversubscribed was Enflame Technology's IPO?
Enflame Technology's IPO retail tranche was oversubscribed 4,073 times , with approximately 7 million online investors submitting orders for 42.1 billion shares . The resulting allocation rate for individual investors was just 0.025 per cent .
How much money is Enflame raising in its Shanghai IPO?
Enflame is raising 6.12 billion yuan (US$910.9 million) through its listing on Shanghai 's Star Market . Shares were priced at 142.18 yuan (US$21.16) each, with proceeds earmarked for fifth- and sixth-generation AI chip research, development, and production.
Who are China's four little dragons in AI chips?
China's AI chip 'four little dragons' are Enflame Technology , Moore Threads , Biren Technology , and MetaX . Enflame is the last of the four to complete a public listing, following its peers onto the Star Market .
How did Moore Threads and MetaX perform at their IPOs?
Moore Threads surged 693 per cent on its first day of trading, while MetaX gained 425 per cent at its debut, both listing in December . These figures are now the benchmark retail investors are using to set expectations for Enflame's first-day performance.
Why is investor demand for Chinese AI chip IPOs so high?
Demand is driven by Beijing 's push for semiconductor self-sufficiency and ongoing US export controls that restrict Chinese firms' access to leading-edge Nvidia hardware. Domestic AI chipmakers like Enflame are seen as strategic beneficiaries, attracting capital from investors with limited alternative exposure to cutting-edge chip technology.
